Science, technology, and innovation in pandemic times: Covid-19 implications

Marco Antonio Vargas, Nathalia Guimarães Alves, Matias Mrejen


The paper analyzes the impacts of the COVID-19 pandemic on the organization of and incentive to science, technology, and innovation in health activities worldwide and nationally, focusing on two aspects. One of them is related to the adopted mechanisms of coordination of and support to these activities in order to manage the pandemic. The other is related to the recent evolution of scientific production on Covid-19. This study highlights the strategic importance of public research and incentive institutions in organizing and coordinating science, technology, and innovation in health activities and the growing incorporation of new technological platforms associated with Industry 4.0. However, there are worldwide asymmetries in the production of scientific knowledge. So, a strategic State approach is crucial in order to coordinate public and private interests regarding health production and guarantee the population’s access to health.


Covid-19; Health Economic-Industrial Complex (HEIC); Science, Technology and Innovation in Health; Bibliometric Analysis; Collaboration Networks

Texto completo:

PDF (English)


ABI YOUNES, G. et al. Covid-19: Insights from Innovation Economists. (Preprint). École Polytechnique Fédérale de Lausanne (EPFL), April 14th, 2020, p. 1-34. DOI:

BAKER, B. U. S. China and EU First Nationalism and Covid-19 Technology Hoarding Push the Rest of the World to the End of the Line. Health GAP. Global Access Project, June 5th, 2020. Availabre: Access: Aug. 3rd, 2020.

CASAS, C. N. P. R. O complexo industrial da saúde na área farmacêutica: uma discussão sobre inovação e acesso no Brasil. 2009. Tese (Doutorado em Ciências na Área de Saúde Pública) – Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Rio de Janeiro, 2009.

COHEN, J. Unveiling ‘Warp Speed’, the White House’s America-first push for a coronavirus vaccine. Science, May 12th, 2020a. DOI:

COHEN, J. Operation Warp Speed’s opaque choices of Covid-19 vaccines draw Senate scrutiny. Science, July 2nd, 2020b. DOI:

DE NEGRI, F.; KOELLER, P. Public Policies for Research and Innovation in the Face of the Covid-19 Crisis. IPEA - Center for Research on Science, Technology and Society, April 6th, 2020. Available: Access: July 30th, 2020.

FAPESP. Vacina em teste no Butantan terá R$ 82,5 milhões da Fapesp e do Todos pela Saúde. Agência FAPESP, 21 ago. 2020. Disponível em: Acesso em: 30 ago. 2020.

FIOCRUZ. Covid-19: Fiocruz firmará acordo para produzir vacina da Universidade de Oxford. Agência Fiocruz, jun. 2020. Disponível em: Acesso em: 30 ago. 2020.

FRENTE PELA VIDA. Plano Nacional de Enfrentamento à Pandemia da Covid-19. Publicado em: 30 jun. 2020. Disponível em: Acesso em: 30 ago. 2020.

GADELHA C. A. G. O complexo industrial da saúde e a necessidade de um enfoque dinâmico na economia da saúde. Ciência & Saúde Coletiva, v. 2, n. 8, p. 521-535. 2003.

HHS. Department of Health and Human Services. Trump Administration Announces Framework and Leadership For Operation Warp Speed. Publicado em: 15 maio 2020. Disponível em: Acesso em 30 jul. 2020.

HHS. Fact Sheet Explaining Operation Warp Speed. Department of Health and Human Services, June 16th, 2020. Available: Access: Sept. 10th, 2020.

KUPFERSCHMIDT, K. ‘Vaccine Nationalism’ Threatens Global Plan to Distribute Covid-19 Shots Fairly. Science, July 28th, 2020. DOI:

LIU, C. et al. Research and Development on Therapeutic Agents and Vaccines for Covid-19 and Related Human Coronavirus Diseases. ACS Central Science, v. 6, n. 3, p. 315-331, 2020. DOI:

OECD. Organisation for Economic Co-operation and Development. Treatments and a vaccine for COVID-19: the need for coordinating policies on R&D, manufacturing and access. In: Tackling coronavirus (COVID-19): contributing to a global effort. [S. l.]: OECD, May 29th, 2020. Available: Access: July 13th, 2020.

TELLEZ, V. M. The Covid-19 Pandemic: R&D and Intellectual Property Management for Access to Diagnostics, Medicines and Vaccines. Policy Brief, n. 73, p. 1-8, abr. 2020. Available: https://ssrn. com/abstract=3640229. Access: July 13th, 2020.

THE LANCET. Covid-19 in Brazil: “So what?”. The Lancet, v. 395, n. 10235, p. 1461, May 9th, 2020.

UNCTAD. United Nations Conference on Trade and Development. The need to protect science, tech- nology and innovation funding during and after the Covid-19 crisis. UNCTAD Policy Brief, n. 80, 2020. Available: Access: July 1st, 2020.

UNIFESP. Universidade Federal de São Paulo. Unifesp participará de teste de vacina para covid-19 desenvolvida por Oxford. UNIFESP, Campus São Paulo, 3 jun. 2020. Disponível em: Acesso em: 12 ago. 2020.

WTO. World Trade Organization. Trade in medical goods in the context of tackling COVID-19: Information note. [S. l.]: WTO, April 3rd, 2020. Available: rese_03apr20_e.pdf. Access: July 30th, 2020.


  • Não há apontamentos.

Licença Creative Commons
Este obra está licenciado com uma Licença Creative Commons Atribuição 4.0 Internacional.